Literature DB >> 25549702

The contribution of non-human primate models to the development of human vaccines.

Tania Rivera-Hernandez1, Diane G Carnathan2, Peter M Moyle3, Istvan Toth4, Nicholas P West1, Paul R Young1, Guido Silvestri2, Mark J Walker1.   

Abstract

The non-human primates (NHPs) model in biomedical research has contributed to the study of human infectious, autoimmune, oncogenic, and neurological diseases. This review focuses on the importance of NHP models in vaccine development for tuberculosis, pertussis, Dengue, group A streptococcus (Streptococcus pyogenes) infection, HIV infection, and certain diseases in the elderly (influenza, for example). From understanding disease pathogenesis and mechanisms of protection, to assessing vaccine safety and efficacy, we discuss selected cases where the importance of the use of NHP models is highlighted.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25549702      PMCID： PMC4465840     

Source DB:  PubMed          Journal:  Discov Med        ISSN： 1539-6509            Impact factor:   2.970


  99 in total

1.  Bacterial determinants of persistent throat colonization and the associated immune response in a primate model of human group A streptococcal pharyngeal infection.

Authors:  C D Ashbaugh; T J Moser; M H Shearer; G L White; R C Kennedy; M R Wessels
Journal:  Cell Microbiol       Date:  2000-08       Impact factor: 3.715

2.  Tracking antigen-specific CD8 T lymphocytes in the lungs of mice vaccinated with the Mtb72F polyprotein.

Authors:  Scott M Irwin; Angelo A Izzo; Steven W Dow; Y A W Skeiky; Steven G Reed; Mark R Alderson; Ian M Orme
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

3.  HIV vaccine development: a new beginning.

Authors:  Merlin Robb
Journal:  Expert Rev Vaccines       Date:  2011-07       Impact factor: 5.217

4.  The classical lancefield antigen of group a Streptococcus is a virulence determinant with implications for vaccine design.

Authors:  Nina M van Sorge; Jason N Cole; Kirsten Kuipers; Anna Henningham; Ramy K Aziz; Ana Kasirer-Friede; Leo Lin; Evelien T M Berends; Mark R Davies; Gordon Dougan; Fan Zhang; Samira Dahesh; Laura Shaw; Jennifer Gin; Madeleine Cunningham; Joseph A Merriman; Julia Hütter; Bernd Lepenies; Suzan H M Rooijakkers; Richard Malley; Mark J Walker; Sanford J Shattil; Patrick M Schlievert; Biswa Choudhury; Victor Nizet
Journal:  Cell Host Microbe       Date:  2014-06-11       Impact factor: 21.023

Review 5.  A nonhuman primate model for preclinical testing of new tuberculosis vaccines.

Authors:  D N McMurray
Journal:  Clin Infect Dis       Date:  2000-06       Impact factor: 9.079

6.  Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity.

Authors:  John W Shiver; Tong-Ming Fu; Ling Chen; Danilo R Casimiro; Mary-Ellen Davies; Robert K Evans; Zhi-Qiang Zhang; Adam J Simon; Wendy L Trigona; Sheri A Dubey; Lingyi Huang; Virginia A Harris; Romnie S Long; Xiaoping Liang; Larry Handt; William A Schleif; Lan Zhu; Daniel C Freed; Natasha V Persaud; Liming Guan; Kara S Punt; Aimin Tang; Minchun Chen; Keith A Wilson; Kelly B Collins; Gwendolyn J Heidecker; V Rose Fernandez; Helen C Perry; Joseph G Joyce; Karen M Grimm; James C Cook; Paul M Keller; Denise S Kresock; Henryk Mach; Robert D Troutman; Lynne A Isopi; Donna M Williams; Zheng Xu; Kathryn E Bohannon; David B Volkin; David C Montefiori; Ayako Miura; Georgia R Krivulka; Michelle A Lifton; Marcelo J Kuroda; Jörn E Schmitz; Norman L Letvin; Michael J Caulfield; Andrew J Bett; Rima Youil; David C Kaslow; Emilio A Emini
Journal:  Nature       Date:  2002-01-17       Impact factor: 49.962

7.  A systematic and functional classification of Streptococcus pyogenes that serves as a new tool for molecular typing and vaccine development.

Authors:  Martina Sanderson-Smith; David M P De Oliveira; Julien Guglielmini; David J McMillan; Therese Vu; Jessica K Holien; Anna Henningham; Andrew C Steer; Debra E Bessen; James B Dale; Nigel Curtis; Bernard W Beall; Mark J Walker; Michael W Parker; Jonathan R Carapetis; Laurence Van Melderen; Kadaba S Sriprakash; Pierre R Smeesters
Journal:  J Infect Dis       Date:  2014-05-05       Impact factor: 5.226

8.  Immunization with C5a peptidase from either group A or B streptococci enhances clearance of group A streptococci from intranasally infected mice.

Authors:  P Patrick Cleary; Yury V Matsuka; Thu Huynh; Hong Lam; Stephen B Olmsted
Journal:  Vaccine       Date:  2004-10-22       Impact factor: 3.641

9.  Humoral and lung immune responses to Mycobacterium tuberculosis infection in a primate model of protection.

Authors:  Noton K Dutta; James McLachlan; Smriti Mehra; Deepak Kaushal
Journal:  Trials Vaccinol       Date:  2014-03-13

10.  Multi high-throughput approach for highly selective identification of vaccine candidates: the Group A Streptococcus case.

Authors:  Giuliano Bensi; Marirosa Mora; Giovanna Tuscano; Massimiliano Biagini; Emiliano Chiarot; Mauro Bombaci; Sabrina Capo; Fabiana Falugi; Andrea G O Manetti; Paolo Donato; Erwin Swennen; Marilena Gallotta; Manuela Garibaldi; Vittoria Pinto; Nico Chiappini; James M Musser; Robert Janulczyk; Massimo Mariani; Maria Scarselli; John L Telford; Renata Grifantini; Nathalie Norais; Immaculada Margarit; Guido Grandi
Journal:  Mol Cell Proteomics       Date:  2012-01-27       Impact factor: 5.911
View more
  17 in total

1.  Evaluation of the immunogenicity of prime-boost vaccination with the replication-deficient viral vectored COVID-19 vaccine candidate ChAdOx1 nCoV-19.

Authors:  Rebecca K McLean; Alexandra J Spencer; Tobias J Tuthill; Teresa Lambe; Simon P Graham; Sandra Belij-Rammerstorfer; Daniel Wright; Marta Ulaszewska; Jane C Edwards; Jack W P Hayes; Veronica Martini; Nazia Thakur; Carina Conceicao; Isabelle Dietrich; Holly Shelton; Ryan Waters; Anna Ludi; Ginette Wilsden; Clare Browning; Dagmara Bialy; Sushant Bhat; Phoebe Stevenson-Leggett; Philippa Hollinghurst; Ciaran Gilbride; David Pulido; Katy Moffat; Hannah Sharpe; Elizabeth Allen; Valerie Mioulet; Chris Chiu; Joseph Newman; Amin S Asfor; Alison Burman; Sylvia Crossley; Jiandong Huo; Raymond J Owens; Miles Carroll; John A Hammond; Elma Tchilian; Dalan Bailey; Bryan Charleston; Sarah C Gilbert
Journal:  NPJ Vaccines       Date:  2020-07-27       Impact factor: 7.344

2.  Whole body MRI of the non-human primate using a clinical 3T scanner: initial experiences.

Authors:  Chun-Xia Li; Xiaodong Zhang
Journal:  Quant Imaging Med Surg       Date:  2017-04

Review 3.  What Is the Predictive Value of Animal Models for Vaccine Efficacy in Humans? Consideration of Strategies to Improve the Value of Animal Models.

Authors:  Ramin Sedaghat Herati; E John Wherry
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-04-02       Impact factor: 10.005

4.  Systemic cytokine and chemokine responses in immunized mice challenged with staphylococcal enterotoxin B.

Authors:  Laura C Hudson Reichenberg; Renu Garg; Raymond Fernalld; Kenneth L Bost; Kenneth J Piller
Journal:  Toxicon       Date:  2017-05-03       Impact factor: 3.033

5.  Arterial spin labeling perfusion magnetic resonance imaging of non-human primates.

Authors:  Xiaodong Zhang; Chun-Xia Li
Journal:  Quant Imaging Med Surg       Date:  2016-10

6.  A core-shell structured COVID-19 mRNA vaccine with favorable biodistribution pattern and promising immunity.

Authors:  Ren Yang; Yao Deng; Baoying Huang; Lei Huang; Ang Lin; Yuhua Li; Wenling Wang; Jingjing Liu; Shuaiyao Lu; Zhenzhen Zhan; Yufei Wang; Ruhan A; Wen Wang; Peihua Niu; Li Zhao; Shiqiang Li; Xiaopin Ma; Luyao Zhang; Yujian Zhang; Weiguo Yao; Xingjie Liang; Jincun Zhao; Zhongmin Liu; Xiaozhong Peng; Hangwen Li; Wenjie Tan
Journal:  Signal Transduct Target Ther       Date:  2021-05-31

7.  Differing Efficacies of Lead Group A Streptococcal Vaccine Candidates and Full-Length M Protein in Cutaneous and Invasive Disease Models.

Authors:  Tania Rivera-Hernandez; Manisha Pandey; Anna Henningham; Jason Cole; Biswa Choudhury; Amanda J Cork; Christine M Gillen; Khairunnisa Abdul Ghaffar; Nicholas P West; Guido Silvestri; Michael F Good; Peter M Moyle; Istvan Toth; Victor Nizet; Michael R Batzloff; Mark J Walker
Journal:  mBio       Date:  2016-06-14       Impact factor: 7.867

8.  Evaluation of the immunogenicity of prime-boost vaccination with the replication-deficient viral vectored COVID-19 vaccine candidate ChAdOx1 nCoV-19.

Authors:  Rebecca K McLean; Alexandra J Spencer; Tobias J Tuthill; Teresa Lambe; Simon P Graham; Sandra Belij-Rammerstorfer; Daniel Wright; Marta Ulaszewska; Jane C Edwards; Jack W P Hayes; Veronica Martini; Nazia Thakur; Carina Conceicao; Isabelle Dietrich; Holly Shelton; Ryan Waters; Anna Ludi; Ginette Wilsden; Clare Browning; Dagmara Bialy; Sushant Bhat; Phoebe Stevenson-Leggett; Philippa Hollinghurst; Ciaran Gilbride; David Pulido; Katy Moffat; Hannah Sharpe; Elizabeth Allen; Valerie Mioulet; Chris Chiu; Joseph Newman; Amin S Asfor; Alison Burman; Sylvia Crossley; Jiandong Huo; Raymond J Owens; Miles Carroll; John A Hammond; Elma Tchilian; Dalan Bailey; Bryan Charleston; Sarah C Gilbert
Journal:  NPJ Vaccines       Date:  2020-07-27       Impact factor: 7.344

9.  Innate and secondary humoral responses are improved by increasing the time between MVA vaccine immunizations.

Authors:  Jean-Louis Palgen; Nicolas Tchitchek; André Rodriguez-Pozo; Quentin Jouhault; Hadjer Abdelhouahab; Nathalie Dereuddre-Bosquet; Vanessa Contreras; Frédéric Martinon; Antonio Cosma; Yves Lévy; Roger Le Grand; Anne-Sophie Beignon
Journal:  NPJ Vaccines       Date:  2020-03-19       Impact factor: 7.344

10.  Comparative analysis of oral-gut microbiota between captive and wild long-tailed macaque in Thailand.

Authors:  Vorthon Sawaswong; Kesmanee Praianantathavorn; Prangwalai Chanchaem; Ariya Khamwut; Taratorn Kemthong; Yuzuru Hamada; Suchinda Malaivijitnond; Sunchai Payungporn
Journal:  Sci Rep       Date:  2021-07-12       Impact factor: 4.379
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.